血管閉鎖装置市場：製品別、エンドユーザー別-2025-2030年の世界予測

血管閉鎖装置市場は、2023年に15億9,000万米ドルと評価され、2024年には17億1,000万米ドルに達すると予測され、CAGR 7.51％で成長し、2030年には26億5,000万米ドルに達すると予測されています。

血管閉鎖装置市場には、カテーテル治療後に血管の開口部を密封し、出血を抑えて治癒を早めるように設計された医療機器が含まれます。これらのデバイスは、血管造影、血管形成術、または動脈アクセスを必要とする処置などのインターベンション処置に不可欠であり、迅速な止血を促進し、患者の早期歩行を可能にします。血管閉鎖器具の必要性は、患者の快適性を高め、処置時間を短縮し、血腫などの合併症を最小限に抑え、医療施設からの早期退院を可能にする能力にあります。主なエンドユーザーには、病院、外来手術センター、カテーテル検査室などがあり、効率と患者の回転率が重要です。

市場の成長を後押ししているのは、心血管疾患の増加、低侵襲手術の進歩、回復が早い手術に対する患者の嗜好の高まりです。さらに、世界人口の高齢化と医療費の増加が需要をさらに押し上げています。コスト効率に優れ、環境に優しい器具の開拓や新興国市場におけるアンメットニーズへの対応には、潜在的なビジネスチャンスが存在します。また、生分解性閉鎖器具の革新や、リアルタイムモニタリングと有効性向上のためのスマート技術の統合も、競争優位性をもたらす可能性があります。

しかし、市場は厳しい規制の枠組みや先端機器の高コストによる制約に直面しており、特に価格に敏感な地域では採用率を阻害する可能性があります。さらに、これらの機器の操作には熟練した労働力が必要なため、運用上の課題もあります。

技術革新の面では、環境的に持続可能でありながら、患者の予後を改善する材料の開発に研究開発の焦点を当てるべきです。スマート・デバイス技術は、リアルタイムのモニタリングや、閉鎖技術の精度向上に有望です。また、十分に浸透していない市場を開拓し、戦略的パートナーシップを結んで流通網を拡大することで、事業の成長がもたらされるかもしれないです。

全体として、血管閉鎖装置市場には大きなビジネスチャンスがあるが、規制、コスト、運営上の課題に対処することが極めて重要です。企業は、製品の差別化を促進するために継続的な研究開発に投資し、この進化する市場の最前線であり続けるために技術の進歩を活用すべきです。

市場力学：急速に進化する血管閉鎖装置市場の主要市場インサイトを公開

血管閉鎖装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患の罹患率の増加
  • 大腿動脈心臓カテーテル治療の人気の高まり
  • VCDの成功率の上昇と止血時間の短縮
• 市場抑制要因
  • 比較的高額な手技費用と、橈骨動脈アクセスを用いた介入手技を好む患者の傾向
• 市場機会
  • 大口径血管閉鎖器具への注目の高まり
  • 患者の不快感や長期安静などの合併症に対処するためのVCDの開発
• 市場の課題
  • VCDに関するリスクと相まって、製品リコールや故障が発生する可能性

ポーターの5つの力：血管閉鎖装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血管閉鎖装置市場における外部からの影響の把握

外部マクロ環境要因は、血管閉鎖装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血管閉鎖装置市場における競合情勢の把握

血管閉鎖装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血管閉鎖装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血管閉鎖装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血管閉鎖装置市場における成功への道筋を描く

血管閉鎖装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の発生率が増加
    • 大腿動脈心臓カテーテル検査の人気の高まり
    • VCDの成功率の向上と止血時間の短縮
  • 抑制要因
    • 手術費用が比較的高く、患者は橈骨動脈アクセスを用いた介入手術を好む傾向がある
  • 機会
    • 大口径血管閉鎖デバイスへの注目の高まり
    • 患者の不快感や長期の臥床などの合併症に対処するためのVCDの開発
  • 課題
    • 製品リコールや故障の可能性とVCD関連のリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血管閉鎖装置市場：製品別

• アクティブ近似器
  • クリップベースのデバイス
  • 縫合ベースのデバイス
• 外部止血器具
• パッシブ近似器
  • コラーゲンプラグ
  • 圧迫補助装置
  • シーラントまたはゲルベースのデバイス

第7章 血管閉鎖装置市場：エンドユーザー別

• 急性期ケア施設
• クリニック
• 病院

第8章 南北アメリカの血管閉鎖装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の血管閉鎖装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの血管閉鎖装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Cardinal Health, Inc.
• Cardiva Medical, Inc.
• Cordis Corporation
• INVAMED
• Medtronic PLC
• Morris Innovative, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Tricol Biomedical, Inc.
• TZ Medical, Inc
• Vasorum Ltd.
• Veryan Medical Ltd
• Vivasure Medical Ltd.
• W. L. Gore & Associates

LIST OF FIGURES

• FIGURE 1. VASCULAR CLOSURE DEVICE MARKET RESEARCH PROCESS
• FIGURE 2. VASCULAR CLOSURE DEVICE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR CLOSURE DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL HEMOSTATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COMPRESSION-ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT- OR GEL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACUTE CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 37. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 38. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 59. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 60. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 63. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 64. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 132. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 133. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 148. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 149. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 152. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 153. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

The Vascular Closure Device Market was valued at USD 1.59 billion in 2023, expected to reach USD 1.71 billion in 2024, and is projected to grow at a CAGR of 7.51%, to USD 2.65 billion by 2030.

The vascular closure device market encompasses medical devices designed to seal openings in blood vessels following catheterization procedures, reducing bleeding and promoting faster healing. These devices are critical for interventional procedures like angiography, angioplasty, or procedures that require arterial access, facilitating quicker hemostasis and enabling early ambulation of patients. The necessity of vascular closure devices lies in their ability to enhance patient comfort, reduce procedure time, minimize complications such as hematoma, and enable faster discharge from medical facilities. Key end-users include hospitals, ambulatory surgical centers, and catheterization labs, where efficiency and patient turnover are critical.

Market growth is propelled by increasing incidences of cardiovascular diseases, advancements in minimally invasive procedures, and rising patient preference for surgeries with quicker recovery times. Moreover, the aging global population and heightened healthcare expenditure further drive demand. Potential opportunities exist in developing cost-efficient, eco-friendly devices and addressing unmet needs in emerging markets. Innovations in biodegradable closure devices and integration of smart technologies for real-time monitoring and enhanced efficacy could also provide a competitive edge.

However, the market faces limitations due to stringent regulatory frameworks and the high cost of advanced devices, which could impede adoption rates, particularly in price-sensitive regions. Furthermore, the skilled labor required to operate these devices poses an operational challenge.

In terms of innovation, research should focus on developing materials that improve patient outcomes while being environmentally sustainable. Smart device technology holds promise for real-time monitoring and improved precision in closure techniques. Business growth may also come from tapping into underpenetrated markets and forming strategic partnerships to expand distribution networks.

Overall, while the vascular closure device market presents significant opportunities, addressing regulatory, cost, and operational challenges is pivotal. Companies should invest in continuous R&D to foster product differentiation and leverage technological advancements to remain at the forefront of this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Closure Device Market

The Vascular Closure Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of cardiovascular diseases globally
  • Rising popularity of femoral artery cardiac catheterization
  • Growing success rate of VCDs and short hemostasis time
• Market Restraints
  • Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
• Market Opportunities
  • Emerging concentration on large-bore vascular closure devices
  • Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
• Market Challenges
  • Probability of product recalls and failure coupled with risks related to VCDs

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Closure Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Closure Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Closure Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Closure Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Closure Device Market

A detailed market share analysis in the Vascular Closure Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Closure Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Closure Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Closure Device Market

A strategic analysis of the Vascular Closure Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Closure Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Cardinal Health, Inc., Cardiva Medical, Inc., Cordis Corporation, INVAMED, Medtronic PLC, Morris Innovative, Inc., Teleflex Incorporated, Terumo Corporation, Tricol Biomedical, Inc., TZ Medical, Inc, Vasorum Ltd., Veryan Medical Ltd, Vivasure Medical Ltd., and W. L. Gore & Associates.

Market Segmentation & Coverage

This research report categorizes the Vascular Closure Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Active Approximators, External Hemostatic Devices, and Passive Approximators. The Active Approximators is further studied across Clip-Based Devices and Suture-Based Devices. The Passive Approximators is further studied across Collagen Plugs, Compression-Assist Devices, and Sealant- or Gel-Based Devices.
• Based on End-User, market is studied across Acute Care Facilities, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of cardiovascular diseases globally
    • 5.1.1.2. Rising popularity of femoral artery cardiac catheterization
    • 5.1.1.3. Growing success rate of VCDs and short hemostasis time
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging concentration on large-bore vascular closure devices
    • 5.1.3.2. Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
  • 5.1.4. Challenges
    • 5.1.4.1. Probability of product recalls and failure coupled with risks related to VCDs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Closure Device Market, by Product

• 6.1. Introduction
• 6.2. Active Approximators
  • 6.2.1. Clip-Based Devices
  • 6.2.2. Suture-Based Devices
• 6.3. External Hemostatic Devices
• 6.4. Passive Approximators
  • 6.4.1. Collagen Plugs
  • 6.4.2. Compression-Assist Devices
  • 6.4.3. Sealant- or Gel-Based Devices

7. Vascular Closure Device Market, by End-User

• 7.1. Introduction
• 7.2. Acute Care Facilities
• 7.3. Clinics
• 7.4. Hospitals

8. Americas Vascular Closure Device Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Vascular Closure Device Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Vascular Closure Device Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Cardinal Health, Inc.
• 3. Cardiva Medical, Inc.
• 4. Cordis Corporation
• 5. INVAMED
• 6. Medtronic PLC
• 7. Morris Innovative, Inc.
• 8. Teleflex Incorporated
• 9. Terumo Corporation
• 10. Tricol Biomedical, Inc.
• 11. TZ Medical, Inc
• 12. Vasorum Ltd.
• 13. Veryan Medical Ltd
• 14. Vivasure Medical Ltd.
• 15. W. L. Gore & Associates